Biosynex

Research Biosynex (ALBIO) on Bullrun: market cap EUR 16.66M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALBIO
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryMedical Devices
• CurrencyEUR
• Market capEUR 16.66M
• Financial periodFY2024
• RevenueEUR 101.17M
• Revenue growth8.8%
• Net income-EUR 43.33M
• Free cash flow-EUR 14.96M
• Gross margin56.8%

Valuation Snapshot

latest market cap is EUR 16.66M.

About Biosynex

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention.

Frequently asked questions

What is Biosynex's market cap?

Biosynex's market capitalization is EUR 16.66M.

What does Biosynex do?

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention.